12-Nov-2026 20:15:02

BHARATROHANGeneral news

BHARATROHAN: ACHIEVES HYPERSPECTRAL IMAGING TECHNOLOGY MILESTONE FOR PHARMA QUALITY SCREENING; TARGETS $0.8–1.8 BN GLOBAL MARKET OPPORTUNITY, REGULATORY DISCUSSIONS UNDERWAY

• Technology Milestone: Successfully demonstrated internal proof-of-concept technology to distinguish genuine pharmaceutical tablets from adulterated or substandard samples without damaging them. • Pharma Expansion: Extending its existing hyperspectral imaging technology from precision agriculture into pharmaceutical quality assurance and anti-counterfeiting. • Drug Testing: Tested analgesics, antibiotics, anti-diabetic medicines and fixed-dose combinations for adulteration and dosage variations. • Adulteration Detection: Identified distinct spectral signatures for chalk, starch, talc and other adulterants, including samples containing 30% adulteration. • Regulatory Engagement: In discussions with multiple Indian regulatory and scientific authorities regarding potential validation and pilot testing. • Global Market Opportunity: Estimates an illustrative total addressable market of $0.8–1.8 billion, with India's opportunity estimated at $100–200 million. • Serviceable Market: Estimates global serviceable addressable market of $80–350 million and India market of $15–50 million. • Three-Year Revenue Opportunity: Illustrative serviceable obtainable market estimated at $1.5–8 million globally and $1–5 million in India over three years. • European Expansion: Netherlands-based subsidiary GroeiGids B.V. provides a platform for engaging European pharmaceutical and technology stakeholders. • Commercialisation Strategy: Exploring partnerships with pharmaceutical manufacturers, testing laboratories, distributors and technology companies for potential pilot evaluations. • Validation Status: Technology remains at the internal proof-of-concept stage; independent validation, regulatory acceptance and commercial deployment are pending. • Management Outlook: Sees significant long-term opportunity in pharmaceutical quality screening, subject to successful technical validation, regulatory approvals and industry adoption.

BHARATROHAN AIRBORNE INNOVATIO

← Back to feed